{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:41Z","timestamp":1793750261095,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2022-COG-101088587"],"award-info":[{"award-number":["ERC-2022-COG-101088587"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2026.114607","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:06:35Z","timestamp":1767715595000},"page":"114607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Optimized lipid nanoparticles for pulmonary delivery of CRISPR\/Cas9 targeting KRAS G12S in lung cancer"],"prefix":"10.1016","volume":"391","author":[{"given":"Moritz","family":"Marschhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"Molbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Winkeljann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Giancaspro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Berninghausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ungewickell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxo","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone P.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114607_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114607_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/1535-7163.MCT-21-0201","article-title":"Characterization of KRAS mutation subtypes in non\u2013small cell lung Cancer","volume":"20","author":"Judd","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.114607_bb0020","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/j.cllc.2019.05.003","article-title":"Outcome differences between first- and second-generation EGFR inhibitors in advanced EGFR mutated NSCLC in a large population-based cohort","volume":"20","author":"Lau","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.jconrel.2026.114607_bb0025","first-page":"8","article-title":"ALK inhibitors in the treatment of ALK positive NSCLC","author":"Khan","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0030","author":"FDA"},{"key":"10.1016\/j.jconrel.2026.114607_bb0035","author":"FDA"},{"key":"10.1016\/j.jconrel.2026.114607_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired resistance to KRASG12C inhibition in Cancer","author":"Awad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114607_bb0045","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jtho.2021.04.015","article-title":"KRAS secondary mutations that confer acquired resistance to KRAS G12C inhibitors, Sotorasib and Adagrasib, and overcoming strategies: insights from in vitro experiments","volume":"16","author":"Koga","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11912-023-01436-y","article-title":"Resistance to KRAS G12C inhibition in non-small cell lung Cancer","volume":"25","author":"Di Federico","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jconrel.2026.114607_bb0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114607_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114607_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.25053","article-title":"Error-prone repair of DNA double-Strand breaks","volume":"231","author":"Rodgers","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0070","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1093\/hmg\/ddq365","article-title":"Loss-of-function variants in the genomes of healthy humans","volume":"19","author":"MacArthur","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2026.114607_bb0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/17425247.2023.2185220","article-title":"Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases","volume":"20","author":"Carneiro","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114607_bb0080","article-title":"Tailoring Hyperbranched poly(\u03b2-amino ester) as a robust and universal platform for cytosolic protein delivery","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114607_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114607_bb0090","author":"FDA"},{"key":"10.1016\/j.jconrel.2026.114607_bb0095","series-title":"Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Moderna COVID-19 Vaccine (2024\u20132025 Formula), for Individuals 6 Months Through 11 Years of Age","author":"FDA","year":"2024"},{"key":"10.1016\/j.jconrel.2026.114607_bb0100","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1021\/acs.molpharmaceut.3c00956","article-title":"Investigations into mRNA lipid nanoparticles shelf-life stability under nonfrozen conditions","volume":"20","author":"Reinhart","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114607_bb0105","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114607_bb0110","author":"FDA"},{"key":"10.1016\/j.jconrel.2026.114607_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114607_bb0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1056\/NEJMoa2405734","article-title":"CRISPR-based therapy for hereditary angioedema","volume":"392","author":"Cohn","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114607_bb0125","author":"Verve Therapeutics, Inc","year":"2024"},{"key":"10.1016\/j.jconrel.2026.114607_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114607_bb0135","author":"FDA"},{"key":"10.1016\/j.jconrel.2026.114607_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114607_bb0145","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114607_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101942","article-title":"Inhaled drug delivery: past, present, and future","volume":"52","author":"Yue","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114607_bb0155","series-title":"RNA Amplif. Anal. Methods Protoc","first-page":"187","article-title":"Fluorescent techniques for RNA detection in nanoparticles","author":"Carneiro","year":"2024"},{"key":"10.1016\/j.jconrel.2026.114607_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107182","article-title":"The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery","volume":"212","author":"Rademacker","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114607_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR edits from sanger trace data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.jconrel.2026.114607_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jconrel.2016.07.048","article-title":"Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer","volume":"238","author":"Borrajo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114607_bb0175","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1039\/D4NR03471F","article-title":"A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer","volume":"17","author":"Chen","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.114607_bb0180","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114607_bb0185","article-title":"Beyond the endosomal bottleneck: understanding the efficiency of mRNA\/LNP delivery","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114607_bb0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2026.114607_bb0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114607_bb0205","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1039\/D4PY00124A","article-title":"Recent developments of polymeric delivery systems in gene therapeutics","volume":"15","author":"Li","year":"2024","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.114607_bb0210","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1021\/jp303267y","article-title":"Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an Electron-dense nanostructured Core","volume":"116","author":"Leung","year":"2012","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2026.114607_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303370","article-title":"Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114607_bb0220","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114607_bb0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1556-276X-7-358","article-title":"Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization","volume":"7","author":"Karaman","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2026.114607_bb0230","doi-asserted-by":"crossref","first-page":"15943","DOI":"10.1039\/C8NR06062B","article-title":"Shape and size of non-spherical silver nanoparticles: implications for calculating nanoparticle number concentrations","volume":"10","author":"Little","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.114607_bb0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/la501789z","article-title":"Making sense of Brownian motion: colloid characterization by dynamic light scattering","volume":"31","author":"Hassan","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.114607_bb0240","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.7150\/thno.42325","article-title":"Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR\/Cas9 induces efficient tumor regression","volume":"10","author":"Gao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114607_bb0245","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ng1380","article-title":"Adeno-associated virus vectors integrate at chromosome breakage sites","volume":"36","author":"Miller","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2026.114607_bb0250","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jconrel.2024.05.015","article-title":"Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation","volume":"370","author":"Atsavapranee","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114607_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23013-2","article-title":"Development of lipid nanoparticles and liposomes reference materials (II): cytotoxic profiles","volume":"12","author":"Syama","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114607_bb0260","first-page":"1","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","author":"Omo-Lamai","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.actbio.2018.05.041","article-title":"Investigation on vascular cytotoxicity and extravascular transport of cationic polymer nanoparticles using perfusable 3D microvessel model","volume":"76","author":"Ahn","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114607_bb0270","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.3390\/cancers13225599","article-title":"Oncogenic KRAS: signaling and drug resistance","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114607_bb0275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/imcb.12194","article-title":"Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages","volume":"97","author":"Guo","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0280","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0285","article-title":"Effect of aerosolized benzalkonium chloride exposure in in vitro cell models using air\u2013liquid interface culture for inhalation toxicity screening","author":"Bang","year":"2025","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jconrel.2026.114607_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120238","article-title":"Visualization of the structure of native human pulmonary mucus","volume":"597","author":"Meziu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114607_bb0295","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114607_bb0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0305","author":"Janvier Labs"},{"key":"10.1016\/j.jconrel.2026.114607_bb0310","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10637-021-01204-4","article-title":"Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo","volume":"40","author":"Song","year":"2022","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2026.114607_bb0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","article-title":"The role of tumor stroma in Cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0320","first-page":"11","article-title":"Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma","author":"Zuo","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114607_bb0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/cam.23131","article-title":"MUC1 and metastatic cancer: expression, function and therapeutic targeting","volume":"7","author":"Horm","year":"2013","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.jconrel.2026.114607_bb0330","series-title":"Odontogenesis Methods Protoc","first-page":"41","article-title":"Detection of apoptosis by TUNEL assay","author":"Kyrylkova","year":"2012"},{"key":"10.1016\/j.jconrel.2026.114607_bb0335","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3390\/cells11142183","article-title":"Crucial role of oncogenic KRAS mutations in apoptosis and autophagy regulation: therapeutic implications","volume":"11","author":"Ferreira","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114607_bb0340","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114607_bb0345","doi-asserted-by":"crossref","DOI":"10.1039\/D5PM00061K","article-title":"Systematic screening of excipients to stabilize aerosolized lipid nanoparticles for enhanced mRNA delivery","author":"Heiser","year":"2025","journal-title":"RSC Pharm."},{"key":"10.1016\/j.jconrel.2026.114607_bb0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13346-023-01402-y","article-title":"Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery","volume":"14","author":"Sarode","year":"2024","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:33:11Z","timestamp":1781771591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":70,"alternative-id":["S0168365926000088"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114607","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized lipid nanoparticles for pulmonary delivery of CRISPR\/Cas9 targeting KRAS G12S in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114607"}}